Diabetes Board decisions

The Board has remanded the case due to insufficient evidence regarding the Veteran's claimed exposure to herbicides in Okinawa, Japan. The claim will be reviewed again with additional development.

The Board has remanded the cases due to the need for further development regarding employment accommodations and their impact on the Veteran's ability to work. The issues of higher rating for type II diabetes mellitus and TDIU are being reconsidered.

The Board has remanded several claims due to the need for updated VA examinations. The Veteran was last examined in December 2015, and there is evidence of worsening since then.

The Board has remanded the case due to procedural issues, including not addressing VA's duty to assist and concerns about the adequacy of the October 2019 VA examination. The Veteran needs to provide records from a hospital in Colorado Springs and a new endocrinologist opinion is needed.

The Veteran's OSA is granted as secondary to his service-connected PTSD. The Board finds that the evidence is evenly balanced as to whether the Veteran's other conditions are related to service, and thus grants them based on this finding.

The Board has remanded the claims for diabetes mellitus type II, hypertension, ED, right knee disability, neck disability, upper back disability, and low back disability due to a pre-decisional duty to assist error regarding in-service exposure to herbicide agents.

The Veteran's service-connected disabilities prevent him from securing or following a substantially gainful occupation since July 1, 2020.,The Veteran submitted VA Form 21-526 for increased evaluation of heart disease, diabetes, prostate cancer residuals, and varicose veins on May 1, 2020.

The Veteran's service-connected conditions do not render him unable to obtain or maintain substantially gainful employment, and his TDIU claim is denied.

The Veteran's claims for ischemic heart disease, diabetes mellitus type II, Parkinson's disease, and PTSD have all been denied as there is no evidence of in-service exposure to herbicides or other factors that would support service connection.,There was no credible supporting evidence found to corroborate the Veteran's claimed service in Vietnam, including his alleged combat service and destruction of an orphanage.

The Veteran's claims for diabetes mellitus, cardioembolic stroke, chronic kidney disease, and chronic lymphocytic leukemia were denied. Service connection was granted with effective date of November 30, 2017, for diabetic polyneuropathy involving the sciatic nerve in both lower extremities.

The Veteran's service connection claims for ischemic heart disease and type II diabetes mellitus are granted due to exposure to Agent Orange in Thailand.

The Board has found the VA's decision to deny PCAFC benefits was inadequate and remanded for an updated medical review. The case is now back with the AOJ for further action.

The Board denied the Veteran's claims for service connection for hypertension, diabetes mellitus, and peripheral vascular disease as there was no evidence of these conditions during or within one year after his military service. The Board also found that exposure to herbicides (Agent Orange) did not occur in Korea, thus denying presumptive service connection based on such exposure.

The Board has remanded the claims for higher ratings and entitlement to TDIU due to incomplete development of records, including VA treatment records. The Veteran's service-connected disabilities are being evaluated by a qualified medical examiner to determine their combined effects on his ability to work.

The Veteran's service connection claims for diabetes mellitus type II and prostate cancer are granted due to presumed exposure to herbicide agents during his service in Thailand, as provided by the PACT Act.

The Veteran's cause of death, coronary artery disease and diabetes mellitus type II, are presumed service-connected due to exposure during his service in Thailand under the PACT Act.

The Veteran's service-connected disabilities did not prevent him from securing or following a substantial gainful occupation prior to December 24, 2014.

The Veteran's DMII with erectile dysfunction is granted a 40 percent disability rating prior to January 21, 2020 and denied for any higher ratings from that date forward.

The Veteran's claim for service connection for diabetes mellitus, type II, due to exposure to chemicals and/or herbicides has been remanded due to lack of substantial compliance with the March 2020 Board remand. The Veteran asserts he was exposed to contaminants including Agent Orange during his active duty service in Guam.

The Board has remanded the Veteran's claims for diabetes mellitus type II, coronary arteriosclerosis, erectile dysfunction (E.D.), bilateral hearing loss, and tinnitus due to incomplete development regarding herbicide exposure in Korea.